SEATTLE, March 5, 2025 /PRNewswire/ -- Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device ® (ISDD ®) technology, today announced groundbreaking new findings from an ...
Designed in collaboration with leading adult and children's hospitals, Steripath Micro is the only FDA 510(k)-cleared low-diversion volume device platform with a specific indication to reduce blood ...
SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the United States Patent Office allowed its patent ...
Steripath Initial Specimen Diversion Device (Magnolia Medical Technologies). The proprietary Steripath Initial Specimen Diversion Device for preventing blood culture contamination enables accurate ...
This unique, proprietary service is exclusively available to Magnolia Medical customers as part of its Mission to ZERO ® standards change management program, which combines evidence-based best ...
The accurate detection of bloodstream infections is central to effective patient management, yet false‐positive results from blood culture contamination continue to impose significant clinical and ...
SAN DIEGO--(BUSINESS WIRE)--Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin ® blood culture collection sets, has sued Magnolia Medical Technologies in the U.S. District Court for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback